Skip to content

DTx 101 Series 

Part 4: FDA Approval Process Guide

Our four-part DTx 101 Series covers various aspects of the Digital Therapeutics (DTx) market to gain a better understanding into defining DTx and market trends, DTx business models, reimbursement considerations, and US FDA regulatory approaches.

Part 4 outlines the FDA approval process for DTx products.

Fill out the form to download Part 4: FDA Approval Process Guide